Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
EnPlusOne Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
EnPlusOne Biosciences

EnPlusOne Biosciences

EnPlusOne: Innovating RNA synthesis and solutions for therapeutic applications at commercial scales.

HQ
Watertown, MA, US
Founded
2022
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize RNA synthesis, EnPlusOne Biosciences focuses on delivering innovative RNA solutions for therapeutic applications. Their core product, the ezRNA™ synthesis platform, enables the incorporation of diverse nucleotide modifications and promises a sustainable manufacturing process capable of producing therapeutic RNA at commercial scales. EnPlusOne aims to support a wide range of RNA solution applications, positioning itself at the forefront of the emerging RNA therapeutics market.

Notable figures in the company include experts in biotechnology and RNA research, though specific names are not provided. EnPlusOne has garnered attention for its stepwise innovation in RNA synthesis, earning recognition within the biotech community. The impact of their ezRNA™ platform is significant, as it offers a scalable and flexible approach to RNA manufacturing, potentially transforming the landscape of RNA-based therapies and solutions.

EnPlusOne Biosciences - Similar Companies

Inceptive logo

Inceptive

inceptive.life

Enzerna logo

Enzerna

enzerna.com

ReNAgade Therapeutics logo

ReNAgade Therapeutics

Ansa Biotechnologies logo

Ansa Biotechnologies

ansabio.com

Replicate Bioscience logo

Replicate Bioscience

Rnav8 Bio logo

Rnav8 Bio

Nextrna Therapeutics logo

Nextrna Therapeutics

Alltrna logo

Alltrna

alltrna.com

Rbio logo

Rbio

rbio.online

Synlife logo

Synlife

synlifebio.com

Orbital Therapeutics logo

Orbital Therapeutics

Laronde logo

Laronde

laronde.bio

EzraBio logo

EzraBio

Sensible Biotechnologies logo

Sensible Biotechnologies

sensible.bio

Silvec Biologics logo

Silvec Biologics

silvec.com

EnPlusOne Biosciences - Quick Facts

Who are EnPlusOne Biosciences' competitors?

Companies similar to EnPlusOne Biosciences include Inceptive, Enzerna, ReNAgade Therapeutics and Ansa Biotechnologies.

When was EnPlusOne Biosciences founded?

EnPlusOne Biosciences was founded in 2022.

Where is EnPlusOne Biosciences' headquarters located?

EnPlusOne Biosciences' headquarters is located in Watertown, MA, US.

When was EnPlusOne Biosciences' last funding round?

EnPlusOne Biosciences' most recent funding round was for $12M (USD) in September 2022.

How much has EnPlusOne Biosciences raised to-date?

As of Sep 30, 2022, EnPlusOne Biosciences has raised a total of $12M (USD).

How many employees does EnPlusOne Biosciences have?

EnPlusOne Biosciences has 8 employees as of Feb 5, 2024.

EnPlusOne Biosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • RNA Synthesis
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research